Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 3
2006 1
2009 1
2010 3
2011 6
2012 5
2013 5
2014 3
2016 3
2017 5
2018 4
2019 1
2020 7
2021 4
2022 3
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Malaria vaccines: facing unknowns.
Palacpac NMQ, Horii T. Palacpac NMQ, et al. F1000Res. 2020 Apr 27;9:F1000 Faculty Rev-296. doi: 10.12688/f1000research.22143.1. eCollection 2020. F1000Res. 2020. PMID: 32399189 Free PMC article. Review.
Editorial: Puzzle pieces from malaria vaccine clinical trials.
Palacpac NMQ, Tiono AB, Mordmüller B, Tsuboi T. Palacpac NMQ, et al. Front Immunol. 2023 Jan 30;14:1138763. doi: 10.3389/fimmu.2023.1138763. eCollection 2023. Front Immunol. 2023. PMID: 36793714 Free PMC article. No abstract available.
Evidence of Artemisinin-Resistant Malaria in Africa.
Balikagala B, Fukuda N, Ikeda M, Katuro OT, Tachibana SI, Yamauchi M, Opio W, Emoto S, Anywar DA, Kimura E, Palacpac NMQ, Odongo-Aginya EI, Ogwang M, Horii T, Mita T. Balikagala B, et al. Among authors: palacpac nmq. N Engl J Med. 2021 Sep 23;385(13):1163-1171. doi: 10.1056/NEJMoa2101746. N Engl J Med. 2021. PMID: 34551228
Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial.
Ouédraogo A, Bougouma EC, Palacpac NMQ, Houard S, Nebie I, Sawadogo J, Berges GD, Soulama I, Diarra A, Hien D, Ouedraogo AZ, Konaté AT, Kouanda S, Myoui A, Ezoe S, Ishii KJ, Sato T, D'Alessio F, Leroy O, Tiono AB, Cousens S, Horii T, Sirima SB. Ouédraogo A, et al. Front Immunol. 2023 Oct 16;14:1267372. doi: 10.3389/fimmu.2023.1267372. eCollection 2023. Front Immunol. 2023. PMID: 37908361 Free PMC article. Clinical Trial.
Artemisinin-Resistant Plasmodium falciparum with High Survival Rates, Uganda, 2014-2016.
Ikeda M, Kaneko M, Tachibana SI, Balikagala B, Sakurai-Yatsushiro M, Yatsushiro S, Takahashi N, Yamauchi M, Sekihara M, Hashimoto M, Katuro OT, Olia A, Obwoya PS, Auma MA, Anywar DA, Odongo-Aginya EI, Okello-Onen J, Hirai M, Ohashi J, Palacpac NMQ, Kataoka M, Tsuboi T, Kimura E, Horii T, Mita T. Ikeda M, et al. Among authors: palacpac nmq. Emerg Infect Dis. 2018 Apr;24(4):718-726. doi: 10.3201/eid2404.170141. Emerg Infect Dis. 2018. PMID: 29553316 Free PMC article.
56 results